コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 neumonia prophylaxis (with cotrimoxazole and pentamidine).
2 iltefosine, paromomycin, amphotericin B, and pentamidine).
3 , miltefosine (hexadecylphosphocholine), and pentamidine.
4 in activity compared to the control compound pentamidine.
5 nosomiasis such as melarsoprol (Arsobal) and pentamidine.
6 20 (70%, 95% CI 48-85.5%) for intralesional pentamidine.
7 ss effective alternatives, often aerosolized pentamidine.
8 istance to paromomycin, amphothericin B, and pentamidine.
9 of 31 [71%]) or 2 doses (31 of 31 [100%]) of pentamidine.
10 ypanosomes often display cross-resistance to pentamidine.
11 nce to existing diamidine therapies, such as pentamidine.
12 t increase was observed with the addition of pentamidine.
13 al and antileishmanial potencies compared to pentamidine.
14 , P. falciparum, and L. donovani compared to pentamidine.
15 rs were more active against L. donovani than pentamidine.
16 vity against L. donovani superior to that of pentamidine.
17 into TbAQP3 renders the latter permeable to pentamidine.
18 tients) vs a positive control (intralesional pentamidine; 20 patients) against L. braziliensis CL in
19 entify the structural determinants that make pentamidine a permeant although most other diamidine dru
22 S100B/RAGE/NFkappaB-dependent manner, since pentamidine, a S100B inhibitor, prevented 5-FU-induced n
23 n to the (AATT)2 binding site, netropsin and pentamidine acquire 26+/-3 and 34+/-2 additional waters
24 tion, plasma membrane P-type H(+)-ATPases to pentamidine action, and trypanothione and several putati
25 ropane (1) was over 25-fold more potent than pentamidine against the drug-resistant isolate KETRI 243
26 hat has been shown to be more effective than pentamidine against the Pneumocystis carinii pathogen in
28 t in contrast to hexadecylphosphocholine and pentamidine, AmB induced gene expression of the inflamma
29 structure illustrates, for the first time, a pentamidine analog capable of binding the "open" form of
30 uded by residue Phe88, but for an asymmetric pentamidine analogue ((Ca)S100B.17), this same channel w
32 tudies were therefore completed here with 23 pentamidine analogues, and X-ray structures of (Ca)S100B
33 se data support a model where dual action of pentamidine and chlorpromazine in mitosis results in syn
34 larsoprol and diamidine compounds similar to pentamidine and furamidine are primarily taken up by try
36 hing was employed to improve the efficacy of pentamidine and Hoechst 33258 ligands that have been sho
44 Twenty two compounds were more potent than pentamidine and seven dications were more effective than
45 ders cells sensitive to both melarsoprol and pentamidine and that loss of AQP2 function could explain
47 istic combination of an antiparasitic agent, pentamidine, and a phenothiazine antipsychotic, chlorpro
48 High-affinity substrates included berberine, pentamidine, and amisulpride, while epinephrine and aten
49 Twenty-six compounds were more active than pentamidine, and seven dications demonstrated increased
50 midino-2-phenylindole (DAPI), netropsin, and pentamidine are minor groove binders that have terminal
52 l analysis to locate an interaction site for pentamidine at phenylalanine 656, a crucial residue in t
55 mino)-5'-deoxyadenosine (MDL 73811), but not pentamidine, berenil, or methylglyoxyl bis(guanylhydrazo
56 rs Hoechst 33258, 4'-diamino-2-phenylindole, pentamidine, berenil, spermine, and spermidine, were tes
58 tween S100B and the drug, and indicates that pentamidine binds into the p53 binding site on S100B def
60 An NMR-docked model of one such inhibitor, pentamidine, bound to Ca(2+)-loaded S100B was calculated
61 The leak currents were partially blocked by pentamidine but showed negligible inhibition by NASP.
62 kdown in Caco-2 cells decreased AP uptake of pentamidine by approximately 50% but did not alter BL up
70 , none significantly impaired sensitivity to pentamidine, diminazene or melarsoprol, relative to the
72 rfloxacin, benzalkonium chloride, cetrimide, pentamidine, etc.) was increased 5- to 30-fold in a Stap
73 minazene, 4',6-diamidino-2-phenylindole, and pentamidine, examine several biophysical and pharmacolog
74 electrophysiological methods, we found that pentamidine exclusively inhibits hERG export from the en
75 ozoal drug 1,5-bis(4-amidinophenoxy)pentane (pentamidine) has been synthesized and tested for in vitr
77 were more potent against P. falciparum than pentamidine (IC(50) = 58 nM), and eight analogues were m
78 models, we observed that targeting SAT1 with pentamidine improved the efficacy of FOLFIRINOX, suggest
79 Replacing TMP/SMX with monthly aerosolized pentamidine in cases of ADR further increased life expec
83 of conformationally restricted congeners of pentamidine in which the flexible pentyl bridge of penta
84 ared with TMP/SMX alone, TMP/SMX followed by pentamidine increased the QALY by 0.07 at an incremental
90 s demonstrates that permeation by dicationic pentamidine is energetically favourable in TbAQP2, drive
92 r with the development of a new oral form of pentamidine isethionate VLX103, led to investigations of
96 gene affecting resistance to the antibiotic pentamidine, our data support a mitochondrial target for
98 te that TbAQP2's unique architecture permits pentamidine permeation through its central pore and show
99 of an effort to inhibit S100B, structures of pentamidine (Pnt) bound to Ca(2+)-loaded and Zn(2+),Ca(2
100 nts of GluD receptor variants and found that pentamidine potently inhibited GluD2-T649A constitutive
101 Both TMP/SMX alone and TMP/SMX followed by pentamidine prophylaxis strategies dominated the no prop
104 tional studies using OCT1-specific substrate pentamidine showed transporter-mediated AP but not BL up
109 ne was transported by an adenosine-sensitive pentamidine transporter (ASPT1) that displayed a K(m) va
110 was mediated by a low-capacity high-affinity pentamidine transporter (HAPT1) and a high-capacity low-
111 ter (HAPT1) and a high-capacity low-affinity pentamidine transporter (LAPT1), with K(m) values of 36
113 In procyclics, an HAPT1-analog (procyclic pentamidine transporter; PPT1) was characterized, but no
117 idine in which the flexible pentyl bridge of pentamidine was replaced by trans-1,2-bismethylenecyclop
118 In bloodstream forms, 50 to 70% of [(3)H]pentamidine was transported by an adenosine-sensitive pe